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Abstract The objective was to investigate the prevalence
and interrelation of migraine and headache in the general
population. Forty thousand men and women aged
20–80 years from the Norwegian general population
received a mailed questionnaire with questions about
migraine and headache. The questionnaire response rate
was 54.5%. The lifetime prevalence of migraine was 26.5%
(95% CI 25.9–27.1%), i.e., 18.1% (95% CI 17.3–18.9%) in
men and 34.1% (95% CI 33.2–35.0%) in women. The
prevalence of migraine decreased slightly in both men
and women after an age of 45. The 1 year prevalence of
headache was 77.2%, i.e., 69.6% (95% CI 68.7–70.6%) in
men and 84.0% (95% CI 83.3–84.7%) in women. The
frequency of headache decreased with age, but some of the
elders aged 70 or above experienced more frequent
headache. The prevalence of being headache free increased
from 19.1% (95% CI 14.2–25.6%) to 74.7% (95% CI
70.0–78.8%) in 20 and 80 years old men without co-
occurrence of migraine, and from 5.1% (95% CI 2.9–8.8%)
to 61.4% (95% CI 54.9–67.6%) in 20 and 80 years old
women without co-occurrence of migraine. Co-occurrence
of migraine significantly increased the frequency of
headache and decreased the prevalence of being headache
free.
Keywords Headache  Migraine  Epidemiology 
Prevalence  Age  General population
Introduction
Headache is the most common type of pain experienced by
man. Even though headache receives little attention prob-
ably due to the often mild symptoms, the fact is that most
people rarely consult their physician for headache [1, 2].
However, the high prevalence and the considerable socio-
economic impact render that suffering from headache
should not be ignored [2–4]. The most common types of
headache, such as migraine and tension-type headache,
cause 270 days and 820 days of work absence per year per
1,000 people [2]. ‘‘Lifting the burden’’, a global campaign
to reduce the burden of headache worldwide concluded that
headache is among the ten most disabling conditions in the
World Health Organizations ranking [4].
The aim of this study is to provide epidemiological data
on migraine and headache among 20–80-year- old people
from the Norwegian general population.
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Subjects and methods
Sampling and representativeness
A random sample of 40,000 persons aged 20, 25, 30, 35,
40, 45, 50, 55, 60, 65, 70, 75 and 80 years was drawn by
the National Population Register. The sample was stratified
by age and gender, i.e., each age group included 2,000
persons of each gender, aged 30–60 years, while the
remaining age groups included 1,000 persons of each
gender. The participants were residing in Akershus, Hed-
mark or Oppland Counties, excluding the municipalities
Asker and Bærum and municipalities north of Trysil,
A˚mot, Ringsaker, Vestre Slidre, Østre Slidre, Gausdal and
Øyer. The sample size was reduced to 38,873 owing to
decease (n = 75), dementia (n = 23), multihandicapped
(n = 4), insufficient Norwegian skills (n = 3), and an error
in the address list (n = 1,024).
The three counties have both rural and urban areas and
Akershus County is situated in close proximity to Oslo.
Data from Statistics Norway show that the sampling area
was representative for the total Norwegian population
regarding age, gender and marital status. Regarding
employment; trade, hotel/restaurant and transport were
overrepresented, while industry, oil and gas and financial
services were underrepresented in the sampling area com-
pared to the total Norwegian population [5].
Questionnaire
All persons received a mailed questionnaire with a standard
letter containing information about the project. Apart from
ensuring confidentiality and emphazising the importance of
participation, it was stated that the object was to study
sleepiness during daytime. The questions ‘‘Have you ever
had migraine? Yes or no’’, and ‘‘How many days during the
last year have you had headache? 0 days, 1–11 days, 12–
30 days, 31–84 days, 85–179 days or C180 days’’ were
used to screen for migraine and headache frequency. If the
questionnaire evoked no response, a second mail was
issued. The replies could be either on paper or electroni-
cally. The data were collected between February and
August 2006. We defined infrequent headache to be less
than 12 days per year, frequent headache to be between 12
and 179 days per year, while chronic headache was
180 days or more per year [1].
Statistical analyses
All questionnaires were scanned using TeleForm v9. The
statistical analyses were performed using SPSS Base Sys-
tem for Windows 15.0. The 95% CI were calculated with
the Vassar Collage statistics web-page [6]. v2 test with 5%
level of significance was used. Non-linear regression
analysis was applied to explore the trends in the prevalence
of different headache frequency, age and gender groups.
Headache frequency can be considered as a count or
ordinal variable. Firstly, the Poisson regression model was
explored, when modeling the differences in headache fre-
quency. Although the assumptions for the Poisson
regression model were reasonable, the fit was rather poor in
this model. Secondly, the ordinal logistic regression model
was considered. However, the assumption of parallel lines
was not met, and this model was rejected. Thus, the
multinomial logistic regression model was estimated to
Table 1 Questionnaire response rates by age and gender
Age Men
% (95% CI)
Women
% (95% CI)
20 30.3 (27.4–33.3) 43.6 (40.4–46.9)
25 30.7 (27.8–33.8) 46.3 (43.1–49.6)
30 38.8 (36.5–41.0) 49.0 (46.8–51.3)
35 42.5 (40.2–44.7) 52.7 (50.4–54.9)
40 50.7 (48.4–52.9) 57.8 (55.6–60.0)
45 51.7 (49.5–54.0) 57.0 (54.8–59.2)
50 54.1 (51.8–56.3) 63.1 (61.0–65.3)
55 59.0 (56.8–61.2) 64.3 (62.2–66.4)
60 60.1 (57.9–62.3) 64.3 (62.2–66.4)
65 70.6 (67.7–73.4) 67.8 (64.8–70.7)
70 70.3 (67.3–73.1) 64.1 (61.0–67.1)
75 64.5 (61.4–67.4) 55.7 (52.5–58.8)
80 55.0 (51.8–58.2) 44.4 (41.3–47.6)
Overall response rate 51.9 (51.2–52.6) 57.0 (56.3–57.7)
CI confidence intervals
Table 2 Lifetime prevalence of migraine related to age and gender
Age Men
% (95% CI)
Women
% (95% CI)
20 21.8 (17.2–27.3) 31.4 (26.9–36.4)
25 22.6 (17.8–28.3) 34.5 (30.0–39.4)
30 20.5 (17.6–23.8) 36.8 (33.6–40–1)
35 21.8 (19.0–25.0) 37.8 (34.7–40.9)
40 22.0 (19.3–24.8) 38.0 (35.1–41.0)
45 20.6 (18.1–23.4) 37.4 (34.5–40.4)
50 18.3 (15.9–20.9) 33.7 (31.0–36.5)
55 18.4 (16.2–20.9) 35.4 (32.7–38.3)
60 18.0 (15.8–20.4) 34.8 (32.2–37.6)
65 14.1 (11.6–17.1) 31.0 (27.4–34.8)
70 11.6 (9.3–14.4) 25.9 (22.5–29.7)
75 13.5 (10.9–16.5) 24.3 (20.7–28.3)
80 10.9 (8.4–14.0) 27.2 (22.9–31.9)
Overall prevalence 18.1 (17.3–18.9) 34.1 (33.2–35.0)
CI confidence intervals
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Table 3 Headache frequency in relation to migraine, age and gender in people from the Norwegian general population
Age
(years)
N No headache Infrequent headache Frequent headache Chronic headache
0 days
(%)
1–11 days
(%)
12–30 days
(%)
31–84 days
(%)
85–179 days
(%)
C180 days
(%)
No migraine
Men
20 202 19.3 55.0 21.3 4.0 0.5 0.0
25 197 15.7 56.9 17.8 8.6 1.0 0.0
30 512 14.8 53.1 19.9 8.0 2.7 1.4
35 563 15.5 56.1 14.9 8.2 3.0 2.3
40 674 16.3 55.0 16.2 8.0 4.0 0.4
45 700 20.4 55.6 12.1 7.7 3.1 1.0
50 754 27.9 50.0 12.9 5.4 2.4 1.5
55 830 35.3 45.3 11.9 4.1 1.6 1.8
60 858 41.7 42.8 9.0 3.6 1.7 1.2
65 517 50.1 39.7 6.6 2.1 0.2 1.4
70 521 56.8 33.0 4.4 4.0 1.0 0.8
75 473 63.8 25.6 4.7 4.2 1.1 0.6
80 395 74.7 15.2 3.3 4.1 1.3 1.5
Total 7,196 34.7 45.2 11.4 5.5 2.0 1.2
Women
20 255 5.1 47.1 25.5 14.1 7.8 0.4
25 262 7.3 45.4 28.2 11.5 5.7 1.9
30 528 8.9 47.2 23.9 11.6 5.9 2.7
35 575 6.8 45.2 24.2 13.9 6.8 3.1
40 646 6.8 46.4 26.0 12.4 6.2 2.2
45 644 10.7 46.7 24.2 12.4 3.4 2.5
50 739 14.6 51.3 20.6 7.8 3.8 1.9
55 711 22.6 48.8 15.5 8.6 3.1 1.4
60 723 23.9 51.0 12.6 6.9 3.0 2.5
65 399 34.6 39.3 11.8 9.0 3.5 1.8
70 400 45.0 35.0 10.8 6.3 1.3 1.8
75 348 51.4 33.9 7.8 5.7 0.6 0.6
80 236 61.4 21.6 8.1 3.4 2.5 3.0
Total 6,466 20.3 45.0 18.8 9.7 4.1 2.1
Co-occurrence of migraine
Men
20 60 1.7 38.3 33.3 18.3 5.0 3.3
25 60 3.3 36.7 31.7 18.3 8.3 1.7
30 138 3.6 28.3 26.8 29.0 6.5 5.8
35 162 3.7 34.6 35.8 17.3 4.9 3.7
40 197 3.0 33.5 28.9 18.3 11.2 5.1
45 191 2.1 35.6 24.1 23.0 8.9 6.3
50 175 5.7 32.0 31.4 17.1 10.3 3.4
55 193 13.0 37.8 24.4 14.0 7.3 3.6
60 196 13.8 47.4 16.3 9.7 7.7 5.1
65 87 19.5 50.6 13.8 11.5 2.3 2.3
70 70 27.1 42.9 15.7 10.0 4.3 0.0
75 74 33.8 25.7 14.9 17.6 4.1 4.1
80 49 30.6 42.9 10.2 14.3 0.0 2.0
Total 1,652 9.8 36.9 24.8 17.1 7.2 4.1
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quantify the differences in headache frequency in relation
to age, gender, age and co-occurrence of migraine.
Ethical issues
The Regional Committees for Medical Research Ethics and
the Norwegian Social Science Data Services approved the
project.
Results
Questionnaire response rate
The overall response rate was 54.5%, and it was signifi-
cantly higher among women than men (P \ 0.001).
Table 1 shows the response rate by age and gender. The
response rate increased steadily from age 20 to age
65 years, and then it slowly declined in the elder age
groups. Among responders, the first, second, and electronic
questionnaire were replied by 64.7, 27.0 and 8.3%,
respectively. There were no significant differences between
headache and migraine response to first, second and elec-
tronic version analyzed separately by age and gender. The
electronic version was replied significantly by more men
than women (men 11.6% vs. women 5.3%; P \ 0.001),
and the response rate increased slightly from age 20 to age
25, then it declined gradually to 1.0 and 0.0% among 80
old men and women (P \ 0.001 in both gender). Infor-
mation about headache was missing in 5.9% of men and
4.8% of women, while information about migraine was
missing in 6.6% of men and 5.2% of women. Complete
information on both headache and migraine was received
by 88.0% of men and 89.4% of women.
Migraine
Table 2 shows the prevalence of migraine by age and
gender. Women had significantly more frequent migraine
than men [34.1% (95% CI 33.2–35.0%) vs. 18.1% (95% CI
25.9–27.1%), P \ 0.001]. The prevalence in men was
unchanged from age 20 to age 40 years, and then it
decreased slightly with age, while the prevalence in women
increased from age 20 to age 40 years, and then decreased
slightly with increasing age.
Headache
The 1 year prevalence of headache was 77.2%, i.e., 69.6%
(95% CI 68.7–70.6%) in men and 84.0% (95% CI 83.3–
84.7%) in women. Table 3 shows headache frequency in
relation to migraine, age and gender. The frequency of
headache decreased with age, but some of the elders aged
70 years or above experienced more frequent headache.
The risk and frequency of headache was significantly
higher in those with than without co-occurrence of
migraine (P \ 0.001 for both the gender). Table 4
presents the results of a multinomial logistic regression
model showing odds ratios in relation to headache
frequency, age and gender, with headache free and age
Table 3 continued
Age
(years)
N No headache Infrequent headache Frequent headache Chronic headache
0 days
(%)
1–11 days
(%)
12–30 days
(%)
31–84 days
(%)
85–179 days
(%)
C180 days
(%)
Women
20 117 0.9 24.8 21.4 30.8 14.5 7.7
25 142 0.0 24.6 30.3 24.6 15.5 4.9
30 323 1.9 22.9 31.6 26.0 10.5 7.1
35 359 0.6 22.3 25.1 30.1 15.3 6.7
40 411 1.0 19.5 27.3 29.7 13.1 9.5
45 392 2.0 22.2 31.9 25.5 10.7 7.7
50 383 3.4 27.9 25.8 22.5 13.1 7.3
55 405 5.4 33.1 28.1 21.0 7.9 4.4
60 408 8.3 39.0 21.6 16.9 7.4 6.9
65 181 15.5 37.0 23.2 13.3 7.2 3.9
70 146 26.7 32.2 18.5 17.8 2.7 2.1
75 112 31.3 34.8 11.6 12.5 4.5 5.4
80 92 39.1 21.7 13.0 16.3 5.4 4.3
Total 3,471 6.6 27.6 25.7 23.2 10.5 6.5
The sum of each row is 100%
342 J Headache Pain (2008) 9:339–347
123
Table 4 Headache analyzed with a multinomial logistic regression model
Age and migraine Men Women
Odds ratios 95% CI P values Odds ratios 95% CI P values
1–11 days
20 0.879 0.583–1.324 0.537 1.384 0.741–2.587 0.308
25 1.069 0.693–1.649 0.764 1.036 0.589–1.820 0.903
30 1.031 0.749–1.420 0.850 0.768 0.505–1.167 0.216
35 1.062 0.782–1.444 0.700 1.051 0.675–1.635 0.827
40 1 – – 1 – –
45 0.826 0.626–1.090 0.176 0.634 0.430–0.934 0.021
50 0.527 0.405–0.684 \0.001 0.508 0.354–0.729 \0.001
55 0.373 0.290–0.480 \0.001 0.325 0.230–0.459 \0.001
60 0.312 0.244–0.400 \0.001 0.313 0.223–0.441 \0.001
65 0.239 0.183–0.313 \0.001 0.169 0.117–0.242 \0.001
70 0.173 0.132–0.227 \0.001 0.107 0.075–0.154 \0.001
75 0.113 0.085–0.151 \0.001 0.092 0.064–0.133 \0.001
80 0.070 0.051–0.096 \0.001 0.048 0.032–0.073 \0.001
Migraine 2.877 2.385–3.470 \0.001 1.981 1.679–2.337 \0.001
No migraine 1 – – 1 – –
12–30 days
20 1.065 0.664–1.708 0.793 1.198 0.629–2.281 0.583
25 1.117 0.675–1.847 0.667 1.090 0.612–1.942 0.769
30 1.241 0.858–1.793 0.252 0.732 0.476–1.127 0.157
35 1.068 0.746–1.530 0.719 0.965 0.612–1.521 0.879
40 1 – – 1 – –
45 0.624 0.444–0.877 0.007 0.619 0.415–0.923 0.019
50 0.494 0.358–0.680 \0.001 0.357 0.244–0.521 \0.001
55 0.317 0.231–0.434 \0.001 0.198 0.137–0.286 \0.001
60 0.190 0.137–0.263 \0.001 0.138 0.095–0.199 \0.001
65 0.116 0.078–0.173 \0.001 0.089 0.059–0.134 \0.001
70 0.079 0.051–0.121 \0.001 0.054 0.036–0.082 \0.001
75 0.070 0.045–0.109 \0.001 0.032 0.020–0.051 \0.001
80 0.042 0.024–0.071 \0.001 0.028 0.017–0.045 \0.001
Migraine 7.666 6.230–9.433 \0.001 4.523 3.797–5.387 \0.001
No migraine 1 – – 1 – –
31–84 days
20 0.587 0.314–1.096 0.094 1.389 0.717–2.691 0.330
25 1.060 0.589–1.909 0.846 0.854 0.464–1.569 0.610
30 1.348 0.884–2.058 0.166 0.643 0.409–1.012 0.056
35 1.027 0.674–1.564 0.901 1.103 0.690–1.762 0.682
40 1 – – 1 – –
45 0.861 0.586–1.266 0.447 0.546 0.359–0.832 0.005
50 0.428 0.289–0.635 \0.001 0.284 0.190–0.426 \0.001
55 0.243 0.163–0.362 \0.001 0.174 0.118–0.257 \0.001
60 0.158 0.105–0.239 \0.001 0.122 0.082–0.182 \0.001
65 0.097 0.057–0.166 \0.001 0.082 0.053–0.128 \0.001
70 0.121 0.074–0.197 \0.001 0.054 0.035–0.085 \0.001
75 0.129 0.081–0.206 \0.001 0.037 0.023–0.061 \0.001
80 0.099 0.059–0.166 \0.001 0.027 0.016–0.048 \0.001
Migraine 11.168 8.896–14.021 \0.001 7.978 6.633–9.596 \0.001
No migraine 1 – – 1 – –
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40 years old as reference categories. Intercept was included
in the model, but is not show in the table. The Pearson v2
values were insignificant for both the models indicating
that the estimated multinomial regression models fit data
reasonably well. Table 5 shows age trends in different
subgroups assessed using the non-linear regression model
for each gender separately. This fit was rather good, with
moderate or high values of R2 and normally distributed
residuals. In some subgroups the linear regression gave
best fit, however,graphical analysis of the data showed that
most subgroups displayed a curvilinear relationship (sec-
ond or third order) between headache frequency and age
(Fig. 1).
Headache free
The prevalence of being headache free increased from
19.1% (95% CI 14.2–25.6%) to 74.7% (95% CI 70.0–
78.8%) in 20 and 80-year-old men without co-occurrence
of migraine, and from 5.1% (95% CI 2.9–8.8%) to 61.4%
(95% CI 54.9–67.6%) in 20 and 80-year-old women
without co-occurrence of migraine. The prevalence of
being headache free increased from 1.7% (95% CI 0.1–
10.1%) to 30.6% (95% CI 18.7–45.6%) in 20 and 80-year-
old men with co-occurrence of migraine, and from 8.5%
(95% CI 0.4–53.6%) to 39.1% (95% CI 29.3–49.9%) in 20
and 80-year-old women with co-occurrence of migraine.
Table 4 continued
Age and migraine Men Women
Odds ratios 95% CI P values Odds ratios 95% CI P values
85–179 days
20 0.226 0.076–0.672 0.007 1.542 0.755–3.151 0.235
25 0.486 0.199–1.185 0.112 1.046 0.540–2.028 0.893
30 0.706 0.396–1.260 0.239 0.620 0.372–1.031 0.066
35 0.637 0.363–1.118 0.116 1.186 0.711–1.979 0.514
40 1 – – 1 – –
45 0.630 0.384–1.033 0.067 0.417 0.256–0.679 \0.001
50 0.400 0.244–0.655 \0.001 0.331 0.210–0.522 \0.001
55 0.197 0.117–0.333 \0.001 0.138 0.086–0.220 \0.001
60 0.174 0.104–0.289 \0.001 0.114 0.072–0.183 \0.001
65 0.026 0.008–0.084 \0.001 0.079 0.046–0.137 \0.001
70 0.064 0.029–0.140 \0.001 0.021 0.010–0.044 \0.001
75 0.058 0.026–0.126 \0.001 0.017 0.007–0.038 \0.001
80 0.040 0.015–0.103 \0.001 0.028 0.014–0.057 \0.001
Migraine 12.664 9.413–17.037 \0.001 8.552 6.856–10.667 \0.001
No migraine 1 – – 1 – –
C180 days
20 0.426 0.092–1.984 0.277 0.751 0.303–1.862 0.536
25 0.262 0.033–2.084 0.205 0.605 0.264–1.388 0.236
30 1.733 0.778–3.861 0.178 0.625 0.349–1.117 0.113
35 1.826 0.852–3.912 0.122 0.941 0.523–1.695 0.839
40 1 – – 1 – –
45 1.156 0.545–2.452 0.705 0.531 0.309–0.913 0.022
50 0.711 0.332–1.523 0.381 0.316 0.186–0.539 \0.001
55 0.606 0.294–1.250 0.175 0.126 0.071–0.221 \0.001
60 0.437 0.210–0.912 0.027 0.177 0.106–0.296 \0.001
65 0.289 0.119–0.699 0.006 0.073 0.037–0.143 \0.001
70 0.120 0.038–0.378 \0.001 0.041 0.019–0.086 \0.001
75 0.163 0.060–0.442 \0.001 0.034 0.015–0.076 \0.001
80 0.209 0.080–0.541 0.001 0.049 0.024–0.103 \0.001
Migraine 12.169 8.498–17.425 \0.001 10.358 7.967–13.467 \0.001
No migraine 1 – – 1 – –
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Discussion
Methodological considerations
The study included 21,177 persons at age 20–80 years,
providing sufficient data for age and gender-specific
prevalence of headache and migraine. Participation was
restricted to those responding to the migraine and headache
questions. The response rate was fair and there were few
missing values. We were not able to investigate whether
responder and non-responders had a similar migraine and
headache pattern, since we were not allowed to contact
non-responders. However, similar replies to the first and
second issued questionnaire as well as electronic responses
suggest that responders and non-responders are not dif-
ferent. A previous Danish epidemiological survey found no
significant difference in the frequency of migraine among
responders and non-responders [7]. The single question
about lifetime occurrence of migraine has been evaluated
against a clinical interview by two physicians in another
Norwegian survey conducted in eastern Akershus County.
The observed agreement rate was 0.81 and Kappa was
0.62, a good strength of agreement (previous unpublished
data). This is in line with validation of two Danish epide-
miological surveys where the observed agreement rate was
0.92 and 0.94, and Kappa was 0.77 and 0.81, respectively
[7, 8]. A single questionnaire question about tension-type
headache has previously been evaluated against a clinical
interview by a physician in a Danish population-based
survey [8]. The observed agreement rate was 0.91 and the
chance corrected agreement rate Kappa was 0.74, i.e., a
good strength of agreement. The frequency of tension-type
headache among 475 persons, aged 25–64-year- old, from
the Danish general population, i.e., none, infrequent, fre-
quent and chronic tension-type headache was also
evaluated against a clinical interview by a physician on the
same day in those with self-reported tension-type head-
ache. The observed agreement rate was 0.87 and the chance
corrected agreement rate Kappa was 0.77, again a good
strength of agreement [9]. Our question regarding headache
is likely to be more or at least equally precise as a single
question about tension-type headache, since everybody
knows what headache is, while some may not know what
tension-type headache is. Thus, our simple questionnaire
on migraine and headache is considered to be valid, even
though our epidemiological survey included persons aged
20–80 years. It would be quite surprising, if 20 years old
and 70–80 years old were significantly different from 25 to
65 years old regarding our simple questions about migraine
and headache. In contrast, questionnaires based on a series
of questions are not valid [8]. Due to the high number of
participants in our survey, it was not feasible to apply the
gold standard, i.e., a clinical interview by a physician/
neurologist with expertise in headache diagnostics. The
prevalence was based on headache within the last year.
This was chosen in order to reduce recall bias. As headache
is usually not a disabling or life threatening disorder, recall
bias is likely to occur if one asks about headache years ago.
Actually, the use of the 1-year prevalence is likely to
secure more precise data on headache. Thus, the method-
ological precautions should secure that the data are both
representative and generalizable.
Migraine
One of our main findings was the 26.5% lifetime preva-
lence of migraine with a male–female sex ratio of
approximately 1:2. Our lifetime prevalence is quite similar
to that found in other epidemiological surveys of
Table 5 The age trends in different subgroups were assessed using the
non-linear regression model for each gender separately
Dependent
variable
Coefficients of regression model P values R2
b0 b1 b2 b3
No migraine
Men
0 days 30.43 -1.12 0.02 – \0.001 0.988
1–11 days 39.34 1.07 -0.02 – \0.001 0.985
12–30 days 27.03 -0.30 – – \0.001 0.957
31–84 days -19.05 1.94 -0.04 0.0003 \0.001 0.869
85–179 days -15.38 1.20 -0.02 0.0001 \0.001 0.855
C180 days -5.54 0.40 -0.01 0.00004 0.197 0.390
Women
0 days 23.04 -1.21 0.02 – \0.001 0.991
1–11 days 22.88 1.32 -0.016 – \0.001 0.835
12–30 days 29.49 -0.03 -0.003 – \0.001 0.924
31–84 days 17.41 -0.16 – – \0.001 0.822
85–179 days 9.20 -0.10 – – \0.001 0.821
C180 days -9.89 0.83 -0.02 0.0001 0.056 0.550
Co-occurrence of migraine
Men
0 days 11.55 -0.62 0.01 – \0.001 0.949
1–11 days 89.72 -4.18 0.09 -0.001 0.306 0.317
12–30 days 43.30 -0.39 – – \0.001 0.804
31–84 days -19.61 3.15 -0.07 0.0005 0.036 0.596
85–179 days -2.99 0.54 -0.006 – 0.005 0.660
C180 days -0.004 0.20 -0.002 – 0.199 0.276
Women
0 days 21.80 -1.33 0.02 – \0.001 0.980
1–11 days 94.78 -5.62 0.13 -0.001 \0.001 0.832
12–30 days 11.94 0.87 -0.01 – \0.001 0.809
31–84 days 36.41 -0.29 – – \0.001 0.778
85–179 days 19.68 -0.20 – – \0.001 0.796
C180 days 9.00 -0.06 – – 0.037 0.338
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Caucasians conducted in Germany, the Netherlands and
Sweden, while it is higher than that found in Canada,
Croatia, Denmark and Italy [7, 10–15]. The different
methodologies of these epidemiological surveys are likely
to explain a part of the variation in prevalence. The prev-
alence of migraine is much lower in Africans, Asians and
South Americans [4]. Although we do not have data on the
frequency of migraine attacks, the high prevalence indicate
that many people experience migraine at least a few times
in their life, supporting the high socioeconomic impact of
migraine [2–4]. The statistically significantly decreased
prevalence of migraine in elder men can be a true phe-
nomenon or it might be caused by recall bias. Women also
had a tendency of decreased prevalence by age, but this
was not statistically significant. Since, the epidemiological
survey was population-based, the prevalence finding can-
not be explained by physician consultation rate differences.
Headache
Another main finding was the 77.2% 1-year prevalence of
headache with a male–female sex ratio of approximately
1:1.2. This corresponds well with the prevalence found in
neighboring countries Denmark, Finland and Sweden [16–
18]. However, another Norwegian epidemiological survey
found a much lower prevalence of headache [19]. The
latter survey was based on the question have you suffered
from headache during the last 12 months? [20]. This
phrasing is likely to cause underestimation of the ‘‘real’’
prevalence of headache, as people with a mild headache
might not reply yes to question about suffering from
headache. An interesting finding was the slightly increased
risk of frequent and chronic tension-type in some of the
elders. Figure 1 gives a graphical presentation of this
aspect. This increase is likely to be secondary to other
causes like stroke, tumors, etc., which become more
common with age. An increase in headache frequency is a
warning sign and should be dealt seriously with proper
investigations. The data clearly demonstrated that co-
occurrence of migraine increased the risk of headache. This
has also been found in other epidemiological surveys [9,
21, 22]. Whether frequent headaches can cause attacks that
mimics migraine or whether abortive attacks of migraine
can be experienced as headache is uncertain. This is cur-
rently being debated among headache researchers, but it is
not the scope of our paper. However, even thought the
etiology is unsolved, the features of migraine and non-
migraine headache are distinct and non-overlapping, as
defined by the explicit diagnostic criteria of the Interna-
tional Classification of Headache Disorders [1]. The
prevalence of being headache free increased significantly
with age, and this is more so in men than in women, and in
those without co-occurrence of migraine than those with
the co-occurrence of migraine. So, even thought a person
Fig. 1 Headache frequency
versus age in men (first row)
and women (second row)
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has frequent episodes of headache and migraine there is
hope at the end of the tunnel.
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